TY - JOUR
T1 - Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis
AU - Chen, Yihong
AU - Gialeli, Chrysostomi
AU - Shen, Junyan
AU - Dunér, Pontus
AU - Walse, Björn
AU - Duelli, Annette
AU - Caing-Carlsson, Rhawnie
AU - Blom, Anna M
AU - Zibert, John R
AU - Nilsson, Anna Hultgårdh
AU - Alenfall, Jan
AU - Liang, Chun
AU - Nilsson, Jan
N1 - Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.
PY - 2024/6/11
Y1 - 2024/6/11
N2 - The osteopontin-derived peptide FOL-005 stimulates hair growth. Using ligand-receptor glyco-capture technology we identified neuropilin-1 (NRP-1), a known co-receptor for vascular endothelial growth factor (VEGF) receptors, as the most probable receptor for FOL-005 and the more stable analogue FOL-026. X-ray diffraction and microscale thermophoresis analysis revealed that FOL-026 shares binding site with VEGF in the NRP-1 b1-subdomain. Stimulation of human umbilical vein endothelial cells with FOL-026 resulted in phosphorylation of VEGFR-2, ERK1/2 and AKT, increased cell growth and migration, stimulation of endothelial tube formation and inhibition of apoptosis in vitro. FOL-026 also promoted angiogenesis in vivo as assessed by subcutaneous Matrigel plug and hind limb ischemia models. NRP-1 knock-down or treatment of NRP-1 antagonist EG00229 blocked the stimulatory effects of FOL-026 on endothelial cells. Exposure of human coronary artery smooth muscle cells to FOL-026 stimulated cell growth, migration, inhibited apoptosis, and induced VEGF gene expression and VEGFR-2/AKT phosphorylation by an NRP-1-dependent mechanism. RNA sequencing showed that FOL-026 activated pathways involved in tissue repair. These findings identify NRP-1 as the receptor for FOL-026 and show that its biological effects mimic that of growth factors binding to the VEGF receptor family. They also suggest that FOL-026 may have therapeutical potential in conditions that require vascular repair and/or enhanced angiogenesis.
AB - The osteopontin-derived peptide FOL-005 stimulates hair growth. Using ligand-receptor glyco-capture technology we identified neuropilin-1 (NRP-1), a known co-receptor for vascular endothelial growth factor (VEGF) receptors, as the most probable receptor for FOL-005 and the more stable analogue FOL-026. X-ray diffraction and microscale thermophoresis analysis revealed that FOL-026 shares binding site with VEGF in the NRP-1 b1-subdomain. Stimulation of human umbilical vein endothelial cells with FOL-026 resulted in phosphorylation of VEGFR-2, ERK1/2 and AKT, increased cell growth and migration, stimulation of endothelial tube formation and inhibition of apoptosis in vitro. FOL-026 also promoted angiogenesis in vivo as assessed by subcutaneous Matrigel plug and hind limb ischemia models. NRP-1 knock-down or treatment of NRP-1 antagonist EG00229 blocked the stimulatory effects of FOL-026 on endothelial cells. Exposure of human coronary artery smooth muscle cells to FOL-026 stimulated cell growth, migration, inhibited apoptosis, and induced VEGF gene expression and VEGFR-2/AKT phosphorylation by an NRP-1-dependent mechanism. RNA sequencing showed that FOL-026 activated pathways involved in tissue repair. These findings identify NRP-1 as the receptor for FOL-026 and show that its biological effects mimic that of growth factors binding to the VEGF receptor family. They also suggest that FOL-026 may have therapeutical potential in conditions that require vascular repair and/or enhanced angiogenesis.
KW - Neuropilin-1/metabolism
KW - Humans
KW - Human Umbilical Vein Endothelial Cells/drug effects
KW - Animals
KW - Neovascularization, Physiologic/drug effects
KW - Osteopontin/metabolism
KW - Cell Movement/drug effects
KW - Vascular Endothelial Growth Factor Receptor-2/metabolism
KW - Cell Proliferation/drug effects
KW - Myocytes, Smooth Muscle/drug effects
KW - Male
KW - Peptides/pharmacology
KW - Vascular Endothelial Growth Factor A/metabolism
KW - Apoptosis/drug effects
KW - Mice, Inbred C57BL
KW - Protein Binding
KW - Ischemia/drug therapy
KW - Mice
KW - Angiogenesis
U2 - 10.1016/j.phrs.2024.107259
DO - 10.1016/j.phrs.2024.107259
M3 - Article
C2 - 38871237
SN - 1096-1186
VL - 205
JO - Pharmacological Research
JF - Pharmacological Research
M1 - 107259
ER -